September 2007

 |
| Lipids |
 |
|
 |
 |
Statins and cancer in the elderly |
| |
by Soko Setoguchi, MD, DrPH |
| |
From the Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. |
 |
 |
| |
Commentary |
 |
Low cholesterol, statins, and cancer risk: déjà vu all over again |
| |
by Peter H. Jones, MD |
 |
 |
 |
| Arrhythmias |
 |
|
 |
 |
Antithrombotic treatment of high-risk elderly patients hospitalized with atrial fibrillation |
| |
by Simona Monte, MScPharmChem1 • Alejandro Macchia, MD1 • Fabio Pellegrini, MStat1 • Marilena Romero, MScPharm1 • Antonio D'Ettorre, MScEngen1 • Luigi Tavazzi, MD2 • Gianni Tognoni, MD1 |
| |
From the 1Department of Clinical Pharmacology and Epidemiology, Consorzio Mario Negri Sud, Santa Maria Imbaro, Chieti; and 2Department of Cardiology, IRCCS Policlinico S. Matteo, Pavia, Italy. |
 |
 |
| |
Case Report |
 |
Beginning antithrombotic therapy in an 84-year-old woman |
 |
 |
| |
Commentary |
 |
Do we need to do a better job of undertaking antithrombotic therapy in the elderly? |
| |
by Peter F. Cohn, MD |
 |
 |
 |
| CAD and Lipids |
 |
|
 |
 |
Achieving LDL cholesterol goals in elderly patients with ACS |
| |
by Lynnette D. Peterson • Kausik K. Ray, MD, MRCP |
| |
From the Department of Public Health and Primary Care, University of Cambridge, United Kingdom |
 |
 |
| |
Case Report |
 |
Statin therapy in an elderly man with ACS |
 |
 |
| |
Commentary |
 |
Never too old for statins |
| |
by Brian G. Kral, MD, MPH • Roger S. Blumenthal, MD |
 |
|
 |
 |
 |
 |
 |


 |
| Departments |
 |

|
|
|
 |
|